These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4999216)

  • 1. Effects of ethionamide and isoxyl on mycolic acid synthesis in Mycobacterium tuberculosis BCG.
    Winder FG; Collins PB; Whelan D
    J Gen Microbiol; 1971 Jun; 66(3):379-80. PubMed ID: 4999216
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the endogenous metabolism of mycobacteria. 2. On the influence of enzyme inhibitors and effective antitubercular substances on 32 P-incorporation].
    Iwainsky H; Reutgen H; Kalich R
    Z Naturforsch B; 1968 Feb; 23(2):211-6. PubMed ID: 4385975
    [No Abstract]   [Full Text] [Related]  

  • 3. Kanamycin in the therapy of pulmonary tuberculosis in the United States.
    Kass I
    Ann N Y Acad Sci; 1966 Jun; 132(2):892-900. PubMed ID: 4960375
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the sensitivity to ethionamide, thiacetazone and isoxyl of tubercle bacilli from previously untreated patients in Tokyo.
    Fukuhara Y; Kobayashi H; Hokama S
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):57-61. PubMed ID: 4097677
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of resistance of Mycobacterium tuberculosis against isonicotinic acid hydrazide, streptomycin, para-aminosalicylic acid, ethionamide, ethambutol and rifampicin using the 32 P incorporation test].
    Reutgen H
    Acta Biol Med Ger; 1973; 30(3):309-16. PubMed ID: 4202698
    [No Abstract]   [Full Text] [Related]  

  • 6. Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis.
    Phetsuksiri B; Jackson M; Scherman H; McNeil M; Besra GS; Baulard AR; Slayden RA; DeBarber AE; Barry CE; Baird MS; Crick DC; Brennan PJ
    J Biol Chem; 2003 Dec; 278(52):53123-30. PubMed ID: 14559907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.
    Phetsuksiri B; Baulard AR; Cooper AM; Minnikin DE; Douglas JD; Besra GS; Brennan PJ
    Antimicrob Agents Chemother; 1999 May; 43(5):1042-51. PubMed ID: 10223912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance of the tuberculosis bacillus to ethionamide, cycloserine, and viomycin noting coexistant resistance to streptomycin, isonicotinic acid, and para-aminosalicylic acid].
    Rudnicka M; Suszko K
    Med Dosw; 1966; 33():291-302. PubMed ID: 4287506
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo studies to assess the suitability of antituberculous drugs for use in intermittent chemotherapy regimens.
    Dickinson JM; Mitchison DA
    Tubercle; 1968 Mar; 49():Suppl:66-70. PubMed ID: 4173333
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of pulmonary tuberculosis with Isoxyl (bacteriological considerations)].
    Taranger J
    Rev Tuberc Pneumol (Paris); 1967; 31(1):68-72. PubMed ID: 4962524
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of antitubercular agents on the endogenous metabolism of mycobacteria].
    Iwainsky H; Reutgen H
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):227-31. PubMed ID: 4973007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Study of tuberculostatic activity and blood concentration of new agents--rifampicin and ethambutol--in patients with pulmonary tuberculosis].
    Mkrtchian SV; Ushkin VV
    Antibiotiki; 1971 May; 16(5):472-7. PubMed ID: 5002224
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbiology of cutaneous tuberculosis.
    Sharma RC; Singh R; Bhatia VN
    Tubercle; 1975 Dec; 56(4):324-8. PubMed ID: 59443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the effect of antituberculosis agents against tubercle bacilli in the resting state, using streptomycin-dependent strain (18-b). I. Studies in vitro].
    Ota Y
    Kekkaku; 1971 Aug; 46(8):295-301. PubMed ID: 4328204
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs.
    Cohn ML; Davis CL
    Am Rev Respir Dis; 1970 Jul; 102(1):97-100. PubMed ID: 4316799
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis.
    Grau T; Selchow P; Tigges M; Burri R; Gitzinger M; Böttger EC; Fussenegger M; Sander P
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1142-5. PubMed ID: 22106218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 18. A common mechanism of inhibition of the Mycobacterium tuberculosis mycolic acid biosynthetic pathway by isoxyl and thiacetazone.
    Grzegorzewicz AE; Korduláková J; Jones V; Born SE; Belardinelli JM; Vaquié A; Gundi VA; Madacki J; Slama N; Laval F; Vaubourgeix J; Crew RM; Gicquel B; Daffé M; Morbidoni HR; Brennan PJ; Quémard A; McNeil MR; Jackson M
    J Biol Chem; 2012 Nov; 287(46):38434-41. PubMed ID: 23002234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the variability of results of sensitivity determination in tuberculosis bacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1968; 128(1):238-47. PubMed ID: 4973009
    [No Abstract]   [Full Text] [Related]  

  • 20. [The resistance of Mycobacterium tuberculosis to ethionamide, thiosemicarbazone and isoxyl and their relations to each other].
    Eule H; Werner E
    Beitr Klin Erforsch Tuberk Lungenkr; 1967; 134(4):247-58. PubMed ID: 4968300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.